Molecular Diagnostics - A way forward to improved patient outcome

Molecular diagnostics is a rapidly advancing field in medical science that uses advanced techniques to detect and analyze genetic and molecular abnormalities in biological samples, such as blood, tissue, or saliva. These techniques involve the detection and analysis of DNA, RNA, and proteins at the molecular level, providing accurate and sensitive diagnostic information for a wide range of diseases and conditions.

Molecular diagnostics has revolutionized the way we diagnose and treat diseases, enabling early detection and personalized medicine tailored to the individual patient's genetic makeup. With its ability to identify disease-causing genetic mutations and biomarkers, molecular diagnostics is increasingly being used to guide treatment decisions, monitor treatment response, and predict disease outcomes.

The use of molecular diagnostics is rapidly expanding, with applications ranging from infectious disease testing, cancer diagnosis and monitoring, and genetic testing for inherited disorders. As technology continues to advance, molecular diagnostics will undoubtedly continue to play a crucial role in the diagnosis and treatment of diseases, improving patient outcomes and advancing the field of medicine.

Our report titled Molecular Diagnostics – A Way Forward to Improved Patient Outcome provides detailed insights into this evolving modality and highlights the following points-

• Reliable diagnosis for communicable infectious diseases like COVID-19, dengue, malaria, tuberculosis, influenza, HIV and hepatitis provided by is molecular diagnostics
• Emerging application areas of molecular diagnostics include genetics, hematopathology, cardiovascular diseases, and neurological diseases
  
• PCR segment dominated the infectious disease molecular diagnostics market & accounted for ~90% revenue in 2020
• Global diagnostics market is dominated by players like Roche and Abbott
• Besides Covid-19 reagents, TB reagents had the highest share in the Indian molecular diagnostics reagent market in 2021.
• The number of testing labs has increased from 14 in February 2020 to 106 VRDLs in March 2022. India currently has 3000+ molecular testing laboratories
• Local players like Molbio, Mylab and TATA MD are striving to make their place in the Indian molecular diagnostics market. Some startups have also raised investments in recent years